Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

Reimbursement Approaches for Radiopharmaceutical Dosimetry: Current Status and Future Opportunities

Stephen A. Graves, Alexandru Bageac, James R. Crowley and Denise A.M. Merlino
Journal of Nuclear Medicine December 2021, 62 (Supplement 3) 48S-59S; DOI: https://doi.org/10.2967/jnumed.121.262752
Stephen A. Graves
1Department of Radiology, University of Iowa, Iowa City, Iowa;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandru Bageac
2Radiology Associates of North Texas, Fort Worth, Texas;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James R. Crowley
3Diagnostic Radiology, Carilion Clinic, Roanoke, Virginia; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Denise A.M. Merlino
4Merlino Healthcare Consulting Corp., Magnolia, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 62 no. Supplement 3 48S-59S
DOI 
https://doi.org/10.2967/jnumed.121.262752
PubMed 
34857622

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication June 22, 2021
  • Revision received September 22, 2021
  • Published online December 2, 2021.

Copyright & Usage 
© 2021 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Stephen A. Graves1,
  2. Alexandru Bageac2,
  3. James R. Crowley3 and
  4. Denise A.M. Merlino4
  1. 1Department of Radiology, University of Iowa, Iowa City, Iowa;
  2. 2Radiology Associates of North Texas, Fort Worth, Texas;
  3. 3Diagnostic Radiology, Carilion Clinic, Roanoke, Virginia; and
  4. 4Merlino Healthcare Consulting Corp., Magnolia, Massachusetts
  1. For correspondence or reprints, contact Stephen A. Graves (stephen-a-graves{at}uiowa.edu).
View Full Text

Statistics from Altmetric.com

Cited By...

  • 14 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Toward Single-Time-Point Image-Based Dosimetry of177Lu-PSMA-617 Therapy
    Julia Brosch-Lenz, Astrid Delker, Friederike Völter, Lena M. Unterrainer, Lena Kaiser, Peter Bartenstein, Sibylle Ziegler, Arman Rahmim, Carlos Uribe, Guido Böning
    Journal of Nuclear Medicine 2023 64 5
  • Developments in Combining Targeted Radionuclide Therapies and Immunotherapies for Cancer Treatment
    Caroline P. Kerr, Joseph J. Grudzinski, Thanh Phuong Nguyen, Reinier Hernandez, Jamey P. Weichert, Zachary S. Morris
    Pharmaceutics 2022 15 1
  • A Primer on Radiopharmaceutical Therapy
    Kilian E. Salerno, Soumyajit Roy, Cathy Ribaudo, Teresa Fisher, Ravi B. Patel, Esther Mena, Freddy E. Escorcia
    International Journal of Radiation Oncology*Biology*Physics 2023 115 1
  • Recent advances and impending challenges for the radiopharmaceutical sciences in oncology
    Suzanne E Lapi, Peter J H Scott, Andrew M Scott, Albert D Windhorst, Brian M Zeglis, May Abdel-Wahab, Richard P Baum, John M Buatti, Francesco Giammarile, Ana P Kiess, Amirreza Jalilian, Peter Knoll, Aruna Korde, Jolanta Kunikowska, Sze Ting Lee, Diana Paez, Jean-Luc Urbain, Jingjing Zhang, Jason S Lewis
    The Lancet Oncology 2024 25 6
  • Radiopharmaceutical supply disruptions and the use of 99mTc-hydroxymethylene diphosphonate as an alternative to 99mTc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement
    Edward J. Miller, Roxana Campisi, Nishant R. Shah, Sean McMahon, Sarah Cuddy, Cesia Gallegos-Kattan, Mathew S. Maurer, Thibaud Damy, Riemer H.J.A. Slart, Ketan Bhatia, Andrew J. Einstein
    Journal of Nuclear Cardiology 2022 29 5
  • Quantitative imaging for 177Lu-PSMA treatment response monitoring and dosimetry
    Catherine Meyer, Laszlo Szidonya, Celeste Winters, Anna Mench, Nadine Mallak, Erik Mittra
    Frontiers in Nuclear Medicine 2023 3
  • Theranostics and Patient-Specific Dosimetry
    Bryan Bednarz
    Seminars in Radiation Oncology 2023 33 3
  • A single-institution experience with 177Lu RPT workflow improvements and qualifying the SPECT/CT imaging for dosimetry
    Siju C. George, Ranjini Tolakanahalli, Santiago Aguirre, Taehyung Peter Kim, E. James Jebaseelan Samuel, Vivek Mishra
    Frontiers in Oncology 2024 14
  • Is Routine Dosimetry Really Happening?
    John J. Sunderland
    Journal of Nuclear Medicine 2025 66 1
  • Radiation Oncologists and Radiopharmaceutical Therapy: Strategies for Addressing Fair Compensation
    Jason M. Beckta, Ravi B. Patel, Gerald A. White, Tom Boike, Freddy E. Escorcia
    Practical Radiation Oncology 2023 13 6

Article usage

Article usage: December 2021 to April 2025

AbstractFullPdf
Dec 20211111106138
Jan 202230913866
Feb 202221610950
Mar 202217514362
Apr 202213514739
May 20227210936
Jun 20224016444
Jul 20224011918
Aug 20223412329
Sep 2022359440
Oct 20225113125
Nov 20222613033
Dec 20223212028
Jan 20233413529
Feb 20234413140
Mar 20232724054
Apr 20232511122
May 20233814743
Jun 20232322342
Jul 20232111332
Aug 20234813747
Sep 20233216132
Oct 20231815932
Nov 20231212529
Dec 2023199720
Jan 20243021250
Feb 20242216852
Mar 20242816248
Apr 20244384291
May 20244321094
Jun 2024916164
Jul 20241619751
Aug 20241917171
Sep 20241116641
Oct 20242013454
Nov 20241632374
Dec 20242720362
Jan 20252114127
Feb 20252327250
Mar 20252121432
Apr 20252830676
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 62 (Supplement 3)
Journal of Nuclear Medicine
Vol. 62, Issue Supplement 3
December 1, 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Reimbursement Approaches for Radiopharmaceutical Dosimetry: Current Status and Future Opportunities
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Reimbursement Approaches for Radiopharmaceutical Dosimetry: Current Status and Future Opportunities
Stephen A. Graves, Alexandru Bageac, James R. Crowley, Denise A.M. Merlino
Journal of Nuclear Medicine Dec 2021, 62 (Supplement 3) 48S-59S; DOI: 10.2967/jnumed.121.262752

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Reimbursement Approaches for Radiopharmaceutical Dosimetry: Current Status and Future Opportunities
Stephen A. Graves, Alexandru Bageac, James R. Crowley, Denise A.M. Merlino
Journal of Nuclear Medicine Dec 2021, 62 (Supplement 3) 48S-59S; DOI: 10.2967/jnumed.121.262752
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • DOSIMETRY FOR RPT
    • PRIMARY STAKEHOLDERS
    • DOSIMETRY TECHNIQUES
    • CPT CODE DESCRIPTIONS
    • SPECIFIC CODING EXAMPLES
    • CURRENT DEFICIENCIES AND FUTURE NEEDS
    • DISCLAIMER
    • DISCLOSURE
    • ACKNOWLEDGMENTS
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Impact of the Reference Multiple-Time-Point Dosimetry Protocol on the Validity of Single-Time-Point Dosimetry for [177Lu]Lu-PSMA-I&T Therapy
  • Toward Single-Time-Point Image-Based Dosimetry of 177Lu-PSMA-617 Therapy
  • Practical Considerations for Implementation of 177Lu-DOTATATE Neuroendocrine Tumor Treatment Programs
  • Radiopharmaceutical Dosimetry for Cancer Therapy: From Theory to Practice
  • Google Scholar

More in this TOC Section

  • Feasibility of Ultra-Low-Activity 18F-FDG PET/CT Imaging Using a Long–Axial-Field-of-View PET/CT System
  • Is Long–Axial-Field-of-View PET/CT Cost-Effective? An International Health–Economic Analysis
  • Multicycle Dosimetric Behavior and Dose–Effect Relationships in [177Lu]Lu-DOTATATE Peptide Receptor Radionuclide Therapy
Show more Clinical Investigation

Similar Articles

Keywords

  • RPT
  • dosimetry
  • SPECT/CT
  • PET/CT
SNMMI

© 2025 SNMMI

Powered by HighWire